SYNGENE INTERNATIONAL
Back to Balance Sheet
|
SYNGENE INTERNATIONAL Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹643 Cr | ₹709 Cr | ₹955 Cr | ₹972 Cr | ₹840 Cr |
What is the latest Total Non-Current Liabilities ratio of SYNGENE INTERNATIONAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹643 Cr |
| Mar2024 | ₹709 Cr |
| Mar2023 | ₹955 Cr |
| Mar2022 | ₹972 Cr |
| Mar2021 | ₹840 Cr |
How is Total Non-Current Liabilities of SYNGENE INTERNATIONAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹643 Cr | -9.24 | |
| Mar2024 | ₹709 Cr | -25.79 | |
| Mar2023 | ₹955 Cr | -1.70 | |
| Mar2022 | ₹972 Cr | 15.72 | |
| Mar2021 | ₹840 Cr | - | |
Compare Total Non-Current Liabilities of peers of SYNGENE INTERNATIONAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SYNGENE INTERNATIONAL | ₹18,342.1 Cr | -5.8% | 10% | -25.2% | Stock Analytics | |
| SAGILITY INDIA | ₹19,656.9 Cr | -6.7% | -2% | 0.3% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹6,373.3 Cr | -0.4% | 1.8% | -31.7% | Stock Analytics | |
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹5,309.2 Cr | -2.9% | 8.5% | 14.7% | Stock Analytics | |
| JUST DIAL | ₹4,438.7 Cr | -2.8% | -4% | -43.1% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹2,275.4 Cr | -18.1% | -12.1% | -47.9% | Stock Analytics | |
SYNGENE INTERNATIONAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SYNGENE INTERNATIONAL | -5.8% |
10% |
-25.2% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses